Prescription drug · ANDA
colchicine NDC 71335-1738
Colchicine .6 mg/1 · Tablet · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-1738-1 | 71335173801 | 30 TABLET in 1 BOTTLE (71335-1738-1)Marketed from Nov 23, 2020 | |
| 71335-1738-2 | 71335173802 | 20 TABLET in 1 BOTTLE (71335-1738-2)Marketed from Jan 28, 2022 | |
| 71335-1738-3 | 71335173803 | 3 TABLET in 1 BOTTLE (71335-1738-3)Marketed from Dec 9, 2020 | |
| 71335-1738-4 | 71335173804 | 12 TABLET in 1 BOTTLE (71335-1738-4)Marketed from Jan 28, 2022 | |
| 71335-1738-5 | 71335173805 | 6 TABLET in 1 BOTTLE (71335-1738-5)Marketed from Jan 28, 2022 | |
| 71335-1738-6 | 71335173806 | 9 TABLET in 1 BOTTLE (71335-1738-6)Marketed from Jan 28, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- colchicine
- Generic name (nonproprietary)
- colchicine
- Active ingredients
- Colchicine — .6 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209876
- Marketing start
- Listing expires
- Other FDA classes
- Alkaloids (Chemical structure)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Interactions (Mechanism)
- Identifiers
- Product ID 71335-1738_ba40dbb7-2983-4797-b285-92fdb5b563d7SPL ID ba40dbb7-2983-4797-b285-92fdb5b563d7SPL set ID 14d4be16-d355-4baf-b4cd-4d97d4b2dca0RxCUI 197541UNII SML2Y3J35T
- Pharmacologic class
- Alkaloid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335173801followed by a unit qualifier and the quantityPackage 71335-1738-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Colchicine tablets are an alkaloid indicated for: • Prophylaxis and treatment of gout flares in adults ( 1.1 ). • Familial Mediterranean fever (FMF) in adults and children 4 years or older ( 1.2 ). 1.1 Gout Flares Colchicine tablets are indicated for prophylaxis and the treatment of acute gout flares. • Prophylaxis of Gout Flares: Colchicine tablets are indicated for prophylaxis of gout flares. • Treatment of Gout Flares: Colchicine tablets are indicated for treatment of acute gout flares when taken at the first sign of a flare. 1.2 Familial Mediterranean Fever (FMF) Colchicine tablets are indicated in adults and children four years or older for treatment of familial Mediterranean fever (FMF…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 209876
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| colchicine | Colchicine .6 mg/1 | TabletOral | Dr.Reddys Laboratories, Inc. | 43598-372 |
| colchicine | Colchicine .6 mg/1 | TabletOral | Proficient Rx LP | 71205-687 |
| colchicine | Colchicine .6 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4000 |
| Colchicine | Colchicine .6 mg/1 | TabletOral | Direct Rx | 72189-331 |